Bridging Australia and India to Commercialise MedTech Innovation
Fusara connects world-class Australian medical innovation with India’s cost-efficient clinical, engineering, and market ecosystems to reduce the cost and accelerate the path to commercialisation.
FUSARA
Bilateral Partnerships for MedTech Growth
Fusion of:
Ideas
Markets
Talents
Problems Facing Australian Medtech Innovators;
Australia has High Clinical Costs
Small Patient Cohorts
Capital Constraints
Too many MedTech innovations fail that shouldn’t
Our Solutions
Australia’s IP + India’s Ecosystem
Cost-efficient Clinical Evaluation & Trials
Faster Validation
Lower Risk
How We Help
Clinical Evaluation & Product Iteration to Achieve Market Fit
